Latest Food and Drug Administration Stories

The DrugRisk Center is the web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com. Chicago, IL (PRWEB) June 08, 2013 The birth control information center at DrugRisk.com is announcing new information on the site for women who have taken the contraceptives Yaz or Yasmin. Records show the number of pending cases filed alleging blood clots has decreased as Bayer reserves compensation for victims*. DrugRisk was created...

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) June 07, 2013 The birth control safety advocates at DrugRisk.com are announcing new information on the site for women using the IUD contraceptive Mirena. The New Jersey Supreme Court recently added a multidistrict court for Mirena claims in that state to join a federal MDL created last month*. The goal of...

Brett Smith for redOrbit.com - Your Universe Online Medical devices have improved, extended, or saved countless lives, but a new study in the Journal of Hospital Medicine showed that these devices can also be a source of harmful complications in children. "Medicine and pediatrics have made amazing advances over the last couple of decades that have resulted in children with congenital diseases and prematurity living longer, so this issue is a by-product of that success," explained lead...

-- BELVIQ Available in US Pharmacies within One Week -- SAN DIEGO, June 7, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported today on the launch of BELVIQ (pronounced BEL-VEEK) in the United States. BELVIQ will be available to patients by prescription in US pharmacies beginning June 11. Eisai Inc. is responsible for the marketing and distribution of BELVIQ under its agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals,...

PARSIPPANY, N.J., June 7, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Propofol Injection 10mg/mL. Actavis' ANDA product is a generic version of Fresenius Kabi's Diprivan(®), which is an intravenously administered sedative and anesthetic. Fresenius Kabi USA, LLC filed suit against Actavis on June 6, 2013, in the U.S. District...

Consumer inquiries about legal rights increase after FDA announces investigation into Victoza and other diabetes drugs over research study linking medications to pancreatitis. Free legal consultations now being offered by Resource4thePeople national network of attorneys. San Diego, CA (PRWEB) June 05, 2013 http://www.resource4thepeople.com/defectivedrugs/victoza-lawsuit.html Resource4thePeople announced today that its attorneys are offering free legal consultations to patients who used...

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Los Angeles, CA (PRWEB) June 06, 2013 The diabetes drug safety center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. A university head of endocrinology and former editor of the American Diabetes Association journal has advised the drug may be connected to pancreatic cancer*. DrugRisk was created to...

This resource will provide consumers access to information about legal rights involving allegations of dangerous side effects, including deep vein thrombosis, filter fracture, migration and perforation from use of filters. Site also includes details of FDA health warning about IVC filter risks the agency is reviewing. San Diego, CA (PRWEB) June 06, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html Resource4thePeople announced today that it is now providing...

CINCINNATI, June 7, 2013 /PRNewswire-USNewswire/ -- As modern medical advances help more children with complex conditions live longer, a new study shows a significant number suffer from complications caused by medical devices that are also necessary for their survival. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Researchers report their findings online June 7 in the Journal of Hospital Medicine. Study authors say their research underscores the continued need to...

BioMedical Life Systems, Inc. (http://www.bmls.com) makers of Leading Prescription Pain Relief devices for Medical Professionals, serving the durable medical equipment (DME) dealer and distributor market - for over 30 years, has received FDA clearance to market its newest innovation, the REBOUND™ Health TENS device, without a prescription. This launch catapults the company into the newly emerging medical retail environment and enables this time tested technology to now be available...